What is Arvinas's operating lease liabilities?

Arvinas (ARVN) reported operating lease liabilities of -$400K in Q1 2026.

How has Arvinas's operating lease liabilities changed year-over-year?

Arvinas's operating lease liabilities increased by 20.0% year-over-year, from -$500K to -$400K.

What is the long-term trend for Arvinas's operating lease liabilities?

Over 3 years (2022 to 2025), Arvinas's operating lease liabilities has grown at a 1.7% compound annual growth rate (CAGR), from -$1.9M to -$2M.

Arvinas ARVN Operating lease liabilities

Operating lease liabilities at other companies

Nurix Therapeutics, Inc.NRIX

——

Monte Rosa Therapeutics, Inc.GLUE

——

ArriVent BioPharma, Inc.AVBP

——

ImmunomeIMNM

——

Olema Pharmaceuticals, Inc.OLMA

——

Inhibrx Biosciences, Inc.INBX

——

Other financials

Income statement

See full

Revenue$15.6M-91.7%

Operating income-$63.8M-189%

Net income-$57.6M-169%

EPS (diluted)-$0.90-179%

Balance sheet

See full

Cash & equivalents$87.3M+7.8%

Total debt$8.6M-19.6%

Total equity$386.8M-41.4%

Total assets$647.5M-35.3%

Cash flow

See full

Operating cash flow-$69.2M+22.2%

CapEx$1.3M+225%

Free cash flow-$70.5M+21.1%

Valuation

See full

Market cap$518.11M-4.6%

Enterprise value$439.41M-7.1%

P/S5.8×+4.5×

Profitability

See full

Operating margin-283.8%-310pp

Net margin-247.5%-260pp

FCF margin-287.4%—

Returns & leverage

See full

Return on equity-42.3%-53.5pp

Debt / equity0×0.0×

Current ratio5.4×+0.9×

Where this comes from

Reported directly by Arvinas in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOperatingLeaseLiability.

The official record: Arvinas’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Arvinas's operating lease liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Arvinas's operating lease liabilities?: Arvinas (ARVN) reported operating lease liabilities of -$400K in Q1 2026.
How has Arvinas's operating lease liabilities changed year-over-year?: Arvinas's operating lease liabilities increased by 20.0% year-over-year, from -$500K to -$400K.
What is the long-term trend for Arvinas's operating lease liabilities?: Over 3 years (2022 to 2025), Arvinas's operating lease liabilities has grown at a 1.7% compound annual growth rate (CAGR), from -$1.9M to -$2M.